Sofía Mickaela Martinez graduated as a pharmacist (2017) and obtained her Ph.D. in Chemical Sciences (2024) from the National University of Córdoba (UNC), Argentina. Since 2018, she has been a teacher in Pharmaceutical Sciences at the same university. During her doctoral studies, she specialized in the design, production, characterization, and evaluation of nanoparticulate systems based on Human Serum Albumin as a Melatonin carrier, aimed at the treatment of neurodegenerative ocular diseases. Currently, she is working as a postdoctoral researcher at the Pharmaceutical Technology Research Unit (UNITEFA) on the National Scientific and Technical Research Council (CONICET). Her postdoctoral research focuses on the development of advanced pharmaceutical systems, including microneedle technologies for the efficient delivery of drugs and hormones.
Ayelen Inda is a pharmacist (UNC, 2018) and recently obtained her Doctorate in Chemical Sciences (2024) at the National University of Córdoba (Argentina). Since 2021, she has worked as a professor in Pharmaceutical Sciences at this institution, where she will also begin her postdoctoral studies. Her doctoral career focused on the research of natural bioactive compounds for the treatment of ocular pathologies, addressing innovations in both the anterior and posterior segments of the eye. Additionally, she led the creation of advanced prodrugs and lipid-based liquid crystalline nanocarrier systems designed to improve biopharmaceutical performance through pharmaceutical design, development, and characterization strategies targeting ocular delivery.
Maximiliano Nicolas Rios is a biochemist with a PhD in Chemical Sciences from the National University of Córdoba (UNC), Argentina. He is currently an assistant professor at the same university and is a postdoctoral fellow at the Center for Research in Biological Chemistry (CIQUIBIC) and the Scientific and Technical Research Council (CONICET). His research project is related to the study of circadian rhythms and the photoregulation of melatonin pathways driven by blue light in the retina.
Abril Bruera Bossio is a recently graduated biotechnologist who completed her degree in 2023 at the National University of Córdoba (UNC). She pursued her professional internship in toxicology at the Institute of Experimental Pharmacology (IFEC-CONICET) to complete her studies. Currently, she is an honorary research intern at the Research and Development Unit in Pharmaceutical Technology (UNITEFA-CONICET), where she participates in various projects focused on developing systems to improve pharmacological treatments.
Mario Eduardo Guido is a full-time professor at the Department of Biological Chemistry “Ranwel Caputto” (DQBRC), School of Chemistry, National University of Córdoba (UNC) in Cordoba, Argentina, and the Principal Research Investigator at the National Research Council of Argentina (CONICET) in the Centro de Investigaciones en Química Biológica de Cordoba (CIQUIBIC)-CONICET UNC. He did a PhD in neurochemistry at the National University of Cordoba (1986-1991) and postdoctoral training in the Departments of Psychology and Pharmacology at Dalhousie University, Halifax, NS, Canada, in neuroscience and chronobiology (1993-1997). Upon his return to Argentina, he established a laboratory at the CIQUIBIC-DQBRC CONICET UNC dedicated to investigating the neurochemical and molecular basis of circadian rhythms and lipid metabolism in the nervous system and the mechanisms of nonvisual phototransduction in the vertebrate retina. At present, his research is focused on the role of glial cells in the retina as novel photodetectors and the temporal regulation of glioma formation and growth in nocturnal mammals. He served as a member of the Nominating Committee of IBRO, the past president of the Argentinean Society for Research in Neuroscience (SAN), a member of the Latin America Academy of Sciences (ACAL), a John Simon Guggenheim Memorial Foundation fellow for Latin-American and Caribe (2009), and currently the director of CIQUIBIC CONICET UNC.
Dr José D. Luna graduated from the Faculty of Medicine at the National University of Cordoba, Argentina. He completed his residency at the Romagosa Private Eye Centre in Cordoba and a two-year postdoctoral fellowship at the Wilmer Eye Institute, Johns Hopkins University (1994-1996). During this fellowship, he gained experience in molecular biology, immunopathology, and experimental retinal electroimmunopathology, working closely with Dr. Stanley Vinores, PhD. Dr. Luna is currently the Head of the Vitreous and Retina Service at the Romagosa Private Eye Centre. In addition to his clinical and teaching activities, Dr Luna is the Secretary of the VER Foundation, which is dedicated to research, teaching, and social assistance in ophthalmology. He has authored more than 85 articles in internationally renowned journals, serves as a reviewer for 22 international ophthalmology journals, and has received eight national awards for his research. Dr. Luna is a member of more than 12 national and international professional associations, including ARVO, where he was a member of the International Committee (2005-2018), and the Ophthalmological Society of Cordoba, where he was Vice President and Acting President (2010-2012). A founding member of AIVO and SARyV, Dr. Luna was President of the Argentine Association for Research in Vision and Ophthalmology (2016-2018).
Daniel Alberto Allemandi is a Pharmacist (1985) and a Doctor in Chemical Sciences (1992) from the National University of Córdoba (UNC), Argentina. He is a full-time professor in the Department of Pharmaceutical Sciences at the same university and a Principal Investigator at the National Scientific and Technical Research Council (CONICET). Currently, he serves as the Operations Manager at the Hemoderivatives Laboratory of UNC. He has also been the Director of the Research and Development Unit in Pharmaceutical Technology (UNITEFA) at UNC and a member of the Permanent Commission of the National Pharmacopoeia (ANMAT). With an extensive research career, he has published more than 120 scientific papers and book chapters and presented over 170 communications at international conferences. He is also a co-author of five patents. His main research areas focus on pharmaceutical technology, particularly developing innovative pharmaceutical systems, including modified drug release systems and nanoparticulate systems. Throughout his career, he has supervised numerous postgraduate scholarships and research projects and has promoted technology transfer to the pharmaceutical industry.
Daniela Alejandra Quinteros is a Pharmacist with a PhD in Chemical Sciences from the National University of Córdoba (UNC), Argentina. She is currently adjunct professor (by competition) of the same university and an independent researcher on the National Scientific and Technical Research Council (CONICET). She completed her postdoctoral study at the Complutense University, Madrid, Bioforge (Biomaterials, Biomimetics, Nanobiotechnology), Universidad De Valladolid, Spain, and University of Campinas, Brasil. Her research project is related to the development of pharmaceutical systems for improvement in the pharmacotherapy of pathologies of high prevalence.
